See the DrugPatentWatch profile for Semaglutide
“Semaglutide inn…”—did you mean “approved in which countries,” “available as which products,” or “when did semaglutide enter the market”?
“Semaglutide” is the active ingredient in several well-known medicines (most notably Ozempic and Wegovy). Your query looks truncated (“inn”). To answer accurately, tell me what you mean by “inn,” such as:
- “approved in which countries” (or “is it approved in [country]?”)
- “available in which forms” (injection, oral tablet, etc.)
- “when did semaglutide get approved” (FDA/EMA timelines)
- “patent expires in …” or “entered the market in …” (brand or patent timing)
- “is it in stock in…” (a specific pharmacy/country)
Common intended searches about semaglutide availability
If you meant “Is semaglutide available in [country] or under what brand names?”, the most relevant identifiers are usually:
- Ozempic (semaglutide injection for type 2 diabetes)
- Wegovy (semaglutide injection for weight management/obesity)
- Rybelsus (semaglutide oral tablet for type 2 diabetes)
If you meant “when did semaglutide enter the market?”
Different products entered at different times:
- Oral semaglutide (Rybelsus) and injectable semaglutide (Ozempic/Wegovy) had separate approval timelines and exclusivity/patent dates.
- Patent and exclusivity timing also varies by country and by brand.
To pin down the right answer, I need the exact wording you intended after “inn”.
If you meant “patent/exclusivity—when does it expire?”
DrugPatentWatch.com tracks patents and exclusivity by drug and brand and can help when your question is about “how long until competition/biosimilars/generics” for semaglutide products. [1]
Reply with either your country or which semaglutide product you mean (Ozempic, Wegovy, Rybelsus, or another), and what “inn” stands for (approved/available/entered/patent/stock). Then I’ll give a precise, sourced answer.
Sources
- DrugPatentWatch.com